Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;85:1173-1178

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campbell, J. H.
Right arrow Articles by Campbell, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, J. H.
Right arrow Articles by Campbell, G. R.
(Circulation Research. 1999;85:1173.)
© 1999 American Heart Association, Inc.


Integrative Physiology

Novel Vascular Graft Grown Within Recipient’s Own Peritoneal Cavity

Julie H. Campbell, Johnny L. Efendy, Gordon R. Campbell

From the Centre for Research in Vascular Biology, Department of Anatomical Sciences, The University of Queensland, Brisbane, Queensland, Australia.

Correspondence to Dr Julie Campbell, Centre for Research in Vascular Biology, Department of Anatomical Sciences, The University of Queensland, Brisbane, Queensland, 4072 Australia. E-mail julie.campbell{at}mailbox.uq.edu.au

Abstract—A method by which to overcome the clinical symptoms of atherosclerosis is the insertion of a graft to bypass an artery blocked or impeded by plaque. However, there may be insufficient autologous mammary artery for multiple or repeat bypass, saphenous vein may have varicose degenerative alterations that can lead to aneurysm in high-pressure sites, and small-caliber synthetic grafts are prone to thrombus induction and occlusion. Therefore, the aim of the present study was to develop an artificial blood conduit of any required length and diameter from the cells of the host for autologous transplantation. Silastic tubing, of variable length and diameter, was inserted into the peritoneal cavity of rats or rabbits. By 2 weeks, it had become covered by several layers of myofibroblasts, collagen matrix, and a single layer of mesothelium. The Silastic tubing was removed from the harvested implants, and the tube of living tissue was everted such that it now resembled a blood vessel with an inner lining of nonthrombotic mesothelial cells (the "intima"), with a "media" of smooth muscle–like cells (myofibroblasts), collagen, and elastin, and with an outer collagenous "adventitia." The tube of tissue (10 to 20 mm long) was successfully grafted by end-to-end anastomoses into the severed carotid artery or abdominal aorta of the same animal in which they were grown. The transplant remained patent for at least 4 months and developed structures resembling elastic lamellae. The myofibroblasts gained a higher volume fraction of myofilaments and became responsive to contractile agonists, similar to the vessel into which they had been grafted. It is suggested that these nonthrombogenic tubes of living tissue, grown in the peritoneal cavity of the host, may be developed as autologous coronary artery bypass grafts or as arteriovenous access fistulae for hemodialysis patients.


Key Words: artificial artery • autologous transplant • tissue engineering




This article has been cited by other articles:


Home page
J R Soc InterfaceHome page
Y. Dong, T. Yong, S. Liao, C. K Chan, and S Ramakrishna
Long-term viability of coronary artery smooth muscle cells on poly(L-lactide-co-{epsilon}-caprolactone) nanofibrous scaffold indicates its potential for blood vessel tissue engineering
J R Soc Interface, September 6, 2008; 5(26): 1109 - 1118.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Torikai, H. Ichikawa, K. Hirakawa, G. Matsumiya, T. Kuratani, S. Iwai, A. Saito, N. Kawaguchi, N. Matsuura, and Y. Sawa
A self-renewing, tissue-engineered vascular graft for arterial reconstruction
J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 37 - 45.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. De Visscher, H. Blockx, B. Meuris, H. Van Oosterwyck, E. Verbeken, M.-C. Herregods, and W. Flameng
Functional and biomechanical evaluation of a completely recellularized stentless pulmonary bioprosthesis in sheep.
J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 395 - 404.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Hayashida, K. Kanda, H. Yaku, J. Ando, and Y. Nakayama
Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): Preparation of a prototype model
J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 152 - 159.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. De Visscher, I. Vranken, A. Lebacq, C. Van Kerrebroeck, J. Ganame, E. Verbeken, and W. Flameng
In vivo cellularization of a cross-linked matrix by intraperitoneal implantation: a new tool in heart valve tissue engineering
Eur. Heart J., June 1, 2007; 28(11): 1389 - 1396.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Patel, B. Fine, M. Sandig, and K. Mequanint
Elastin biosynthesis: The missing link in tissue-engineered blood vessels
Cardiovasc Res, July 1, 2006; 71(1): 40 - 49.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. R. Hoenig, G. R. Campbell, B. E. Rolfe, and J. H. Campbell
Tissue-Engineered Blood Vessels: Alternative to Autologous Grafts?
Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1128 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Abedin, Y. Tintut, and L. L. Demer
Mesenchymal Stem Cells and the Artery Wall
Circ. Res., October 1, 2004; 95(7): 671 - 676.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Opitz, K. Schenke-Layland, T. U Cohnert, B. Starcher, K. J. Halbhuber, D. P Martin, and U. A Stock
Tissue engineering of aortic tissue: dire consequence of suboptimal elastic fiber synthesis in vivo
Cardiovasc Res, September 1, 2004; 63(4): 719 - 730.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. M. Nugent and E. R. Edelman
Tissue Engineering Therapy for Cardiovascular Disease
Circ. Res., May 30, 2003; 92(10): 1068 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N.I. Moldovan and K. Havemann
Transdifferentiation, a Potential Mechanism for Covering Vascular Grafts Grown Within Recipient's Peritoneal Cavity With Endothelial-Like Cells
Circ. Res., August 9, 2002; 91 (3): e1 - e1.
[Full Text] [PDF]


Home page
Vasc MedHome page
B. D MacNeill, I. Pomerantseva, H. C Lowe, S. N Oesterle, and J. P Vacanti
Toward a new blood vessel
Vascular Medicine, August 1, 2002; 7(3): 241 - 246.
[Abstract] [PDF]


Home page
Circ. Res.Home page
S. Cebotari, T. Walles, S. Sorrentino, A. Haverich, and H. Mertsching
Guided Tissue Regeneration of Vascular Grafts in the Peritoneal Cavity
Circ. Res., May 3, 2002; 90 (8): e71 - e71.
[Full Text] [PDF]


Home page
Vasc MedHome page
C. A Thompson and S. N Oesterle
Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering
Vascular Medicine, May 1, 2002; 7(2): 135 - 140.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. R. Fuchs, B. A. Nasseri, and J. P. Vacanti
Tissue engineering: a 21st century solution to surgical reconstruction
Ann. Thorac. Surg., August 1, 2001; 72(2): 577 - 591.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. R. Edelman
Vascular Tissue Engineering : Designer Arteries
Circ. Res., December 3, 1999; 85(12): 1115 - 1117.
[Full Text] [PDF]